San Diego Life Sciences Roundup: Evoke Pharma, Isis, Otonomy, & More
(Page 2 of 5)
a recent regulatory filing. The company intends to raise $73.6 million, and would have an initial market cap of approximately $189.5 million, were it to price in the middle of its range. It will trade on the Nasdaq under ticker symbol FATE. Fate has raised over $42 million in venture funding from Arch Venture Partners (16.8 percent ownership pre-IPO), Polaris Partners (16.8 percent), Venrock (16.8 percent), and OVP Venture Partners (15.4 percent).
—Qualcomm (NASDAQ: QCOM), the San Diego wireless technologies giant, said its Qualcomm Life subsidiary unveiled its 2net Mobile technology platform at the Uplinq 2013 developers conference in downtown San Diego. Qualcomm said its 2net Mobile wireless technology enables healthcare providers to collect and aggregate clinical data from multiple medical device sensors so it can be distributed across a variety of mobile phones and tablets, Qualcomm said the system has been designed to meet privacy and security requirements set by the government.
—San Diego-based Accelrys (NASDAQ: [[ticker:ACCL) said it acquired the environmental health and safety specialist ChemSW, which provides on-premises and cloud-based technology to help customers manage their chemical inventory and environmental health and safety compliance programs. Accelrys agreed to pay ChemSW shareholders a total of $15.3 million in cash, and certain executives could receive as … Next Page »